A Phase II Trial of TGF beta Type I Receptor Inhibitor, Galunisertib, plus Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer
T. Yamazaki,A. J. Gunderson,M. Gilchrist,M. Whiteford,M. X. Kiely,A. Hayman,D. P. O'Brien,R. Ahmad,J. V. Manchio, N. Fox, K. McCarty, M. Phillips,E. Brosnan,G. Vaccaro,R. Li,M. Simon, E. Bernstein,M. McCormick, L. Yamasaki,A. Drokin, T. Carnahan, Y. Y. To,W. L. Redmond, B. Lee, J. Louie, E. K. Hansen, M. C. Solhjem,J. Cramer,W. J. Urba,M. Gough,M. R. Crittenden,K. H. Young JOURNAL OF CLINICAL ONCOLOGY(2022)
AI 理解论文
溯源树
样例